Eneboparatide

AZP-3601 · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eneboparatide, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism [Phase 3]

See pricing